Device_News

Articles

A recent article posted in Clinical Lab Products (CLP) by Professor Sepehr Tabrizi, Royal Women’s Hospital, Melbourne, describes our current understanding of Mycoplasma genitalium, the rise of treatment failure due...

Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia. “The SpeeDx assay provides...

Austrade’s Success Stories article highlights our focus in tackling the growing threat of antimicrobial resistance using precision medicine. SpeeDx develops clinical diagnostic tests which are faster and more accurate in...

Genomeweb highlights the launch of SpeeDx’ STI and antimicrobial resistance test. During the interview, Colin Denver – the Vice President of Sales and Marketing of SpeeDx – emphasized our track...